Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.

Yihu Zheng; Shengchu Zhang; Hooi Min Tan Grahn; Chao Ye; Zheng Gong; Qiyu Zhang

doi:10.5812/hepatmon.6496

Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.

Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong, Qiyu Zhang

Boston University

Research output: Contribution to journal › Article › peer-review

153 Downloads (Pure)

Abstract

Raising the chemotherapy-induced HBV reactivation is parallel to the increment of chemotherapy treatments in breast cancer patients. This meta-analysis aims to evaluate the efficacy of prophylactic use of lamivudine in breast cancer patients with HBsAg positive during chemotherapy.

Original language	English
Pages (from-to)	e6496
Journal	Hepatitis Monthly
Volume	13
Issue number	4
DOIs	https://doi.org/10.5812/hepatmon.6496
Publication status	Published - 2013
Externally published	Yes

Subject classification (UKÄ)

Hematology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5812/hepatmon.6496

Zheng_et_al

http://www.ncbi.nlm.nih.gov/pubmed/23805156?dopt=Abstract

Cite this

@article{cfb54afdd4df42c4aaae6274307af313,

title = "Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.",

abstract = "Raising the chemotherapy-induced HBV reactivation is parallel to the increment of chemotherapy treatments in breast cancer patients. This meta-analysis aims to evaluate the efficacy of prophylactic use of lamivudine in breast cancer patients with HBsAg positive during chemotherapy.",

author = "Yihu Zheng and Shengchu Zhang and {Tan Grahn}, {Hooi Min} and Chao Ye and Zheng Gong and Qiyu Zhang",

year = "2013",

doi = "10.5812/hepatmon.6496",

language = "English",

volume = "13",

pages = "e6496",

journal = "Hepatitis Monthly",

issn = "1735-143X",

publisher = "Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran",

number = "4",

}

TY - JOUR

T1 - Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.

AU - Zheng, Yihu

AU - Zhang, Shengchu

AU - Tan Grahn, Hooi Min

AU - Ye, Chao

AU - Gong, Zheng

AU - Zhang, Qiyu

PY - 2013

Y1 - 2013

N2 - Raising the chemotherapy-induced HBV reactivation is parallel to the increment of chemotherapy treatments in breast cancer patients. This meta-analysis aims to evaluate the efficacy of prophylactic use of lamivudine in breast cancer patients with HBsAg positive during chemotherapy.

AB - Raising the chemotherapy-induced HBV reactivation is parallel to the increment of chemotherapy treatments in breast cancer patients. This meta-analysis aims to evaluate the efficacy of prophylactic use of lamivudine in breast cancer patients with HBsAg positive during chemotherapy.

U2 - 10.5812/hepatmon.6496

DO - 10.5812/hepatmon.6496

M3 - Article

C2 - 23805156

SN - 1735-143X

VL - 13

SP - e6496

JO - Hepatitis Monthly

JF - Hepatitis Monthly

IS - 4

ER -

Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this